Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biopharma industry
Pharma
2025's top biopharma M&A deals
Looming patent expirations and a thawing of the biotech investment scene prompted drug developers of all stripes to pull out their checkbooks in 2025.
Fraiser Kansteiner
,
Zoey Becker
,
Angus Liu
,
Kevin Dunleavy
,
Eric Sagonowsky
,
Andrea Park
Jan 12, 2026 3:00am
3 biopharma CEOs explain why they are 'authentically optimistic'
Jan 6, 2026 11:54am
2024's top biopharma M&A deals
Brought to you by
Pfizer
Argenx telegraphs CEO switch as chief drug Vyvgart rolls ahead
Jan 5, 2026 2:12pm
Pfizer plots hundreds of Swiss layoffs by year-end: Bloomberg
Dec 11, 2025 9:23am
Regulatory, policy uncertainties harm biopharma planning: Cytiva
Oct 8, 2025 3:11pm
